Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explants

Gene therapy is a rapidly developing field, and adeno-associated viruses (AAVs) are a leading viral-vector candidate for therapeutic gene delivery. Newly engineered AAVs with improved abilities are now entering the clinic. It has proven challenging, however, to predict the translational potential of...

Full description

Bibliographic Details
Main Authors: Zhouhuan Xi, Bilge E. Öztürk, Molly E. Johnson, Serhan Turunç, William R. Stauffer, Leah C. Byrne
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050122000626
_version_ 1818206858032185344
author Zhouhuan Xi
Bilge E. Öztürk
Molly E. Johnson
Serhan Turunç
William R. Stauffer
Leah C. Byrne
author_facet Zhouhuan Xi
Bilge E. Öztürk
Molly E. Johnson
Serhan Turunç
William R. Stauffer
Leah C. Byrne
author_sort Zhouhuan Xi
collection DOAJ
description Gene therapy is a rapidly developing field, and adeno-associated viruses (AAVs) are a leading viral-vector candidate for therapeutic gene delivery. Newly engineered AAVs with improved abilities are now entering the clinic. It has proven challenging, however, to predict the translational potential of gene therapies developed in animal models due to cross-species differences. Human retinal explants are the only available model of fully developed human retinal tissue and are thus important for the validation of candidate AAV vectors. In this study, we evaluated 18 wild-type and engineered AAV capsids in human retinal explants using a recently developed single-cell RNA sequencing (RNA-seq) AAV engineering pipeline (scAAVengr). Human retinal explants retained the same major cell types as fresh retina, with similar expression of cell-specific markers except for a photoreceptor population with altered expression of photoreceptor-specific genes. The efficiency and tropism of AAVs in human explants were quantified with single-cell resolution. The top-performing serotypes, K91, K912, and 7m8, were further validated in non-human primate and human retinal explants. Together, this study provides detailed information about the transcriptome profiles of retinal explants and quantifies the infectivity of leading AAV serotypes in human retina, accelerating the translation of retinal gene therapies to the clinic.
first_indexed 2024-12-12T04:19:42Z
format Article
id doaj.art-0b6055e7153143f08ae34481985f349e
institution Directory Open Access Journal
issn 2329-0501
language English
last_indexed 2024-12-12T04:19:42Z
publishDate 2022-06-01
publisher Elsevier
record_format Article
series Molecular Therapy: Methods & Clinical Development
spelling doaj.art-0b6055e7153143f08ae34481985f349e2022-12-22T00:38:20ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012022-06-0125476489Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explantsZhouhuan Xi0Bilge E. Öztürk1Molly E. Johnson2Serhan Turunç3William R. Stauffer4Leah C. Byrne5Department of Ophthalmology, University of Pittsburgh, PA, USA; Eye Center of Xiangya Hospital, Hunan Key Laboratory of Ophthalmology, Central South University, Changsha, Hunan, ChinaDepartment of Ophthalmology, University of Pittsburgh, PA, USADepartment of Ophthalmology, University of Pittsburgh, PA, USADepartment of Ophthalmology, University of Pittsburgh, PA, USADepartment of Neurobiology, University of Pittsburgh, PA, USADepartment of Ophthalmology, University of Pittsburgh, PA, USA; Department of Neurobiology, University of Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh, PA, USA; Corresponding author Leah C. Byrne, Department of Ophthalmology, University of Pittsburgh, PA, USA.Gene therapy is a rapidly developing field, and adeno-associated viruses (AAVs) are a leading viral-vector candidate for therapeutic gene delivery. Newly engineered AAVs with improved abilities are now entering the clinic. It has proven challenging, however, to predict the translational potential of gene therapies developed in animal models due to cross-species differences. Human retinal explants are the only available model of fully developed human retinal tissue and are thus important for the validation of candidate AAV vectors. In this study, we evaluated 18 wild-type and engineered AAV capsids in human retinal explants using a recently developed single-cell RNA sequencing (RNA-seq) AAV engineering pipeline (scAAVengr). Human retinal explants retained the same major cell types as fresh retina, with similar expression of cell-specific markers except for a photoreceptor population with altered expression of photoreceptor-specific genes. The efficiency and tropism of AAVs in human explants were quantified with single-cell resolution. The top-performing serotypes, K91, K912, and 7m8, were further validated in non-human primate and human retinal explants. Together, this study provides detailed information about the transcriptome profiles of retinal explants and quantifies the infectivity of leading AAV serotypes in human retina, accelerating the translation of retinal gene therapies to the clinic.http://www.sciencedirect.com/science/article/pii/S2329050122000626AAVretinascRNA-seqgene therapyhuman retinal explant
spellingShingle Zhouhuan Xi
Bilge E. Öztürk
Molly E. Johnson
Serhan Turunç
William R. Stauffer
Leah C. Byrne
Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explants
Molecular Therapy: Methods & Clinical Development
AAV
retina
scRNA-seq
gene therapy
human retinal explant
title Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explants
title_full Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explants
title_fullStr Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explants
title_full_unstemmed Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explants
title_short Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explants
title_sort quantitative single cell transcriptome based ranking of engineered aavs in human retinal explants
topic AAV
retina
scRNA-seq
gene therapy
human retinal explant
url http://www.sciencedirect.com/science/article/pii/S2329050122000626
work_keys_str_mv AT zhouhuanxi quantitativesinglecelltranscriptomebasedrankingofengineeredaavsinhumanretinalexplants
AT bilgeeozturk quantitativesinglecelltranscriptomebasedrankingofengineeredaavsinhumanretinalexplants
AT mollyejohnson quantitativesinglecelltranscriptomebasedrankingofengineeredaavsinhumanretinalexplants
AT serhanturunc quantitativesinglecelltranscriptomebasedrankingofengineeredaavsinhumanretinalexplants
AT williamrstauffer quantitativesinglecelltranscriptomebasedrankingofengineeredaavsinhumanretinalexplants
AT leahcbyrne quantitativesinglecelltranscriptomebasedrankingofengineeredaavsinhumanretinalexplants